Perfluorobutanesulfonic acid (PFBS), a short-chain alternative to perfluorooctanesulfonic
acid (PFOS), is widely used in various products and is increasingly present in environmental …

Emerging epidemiological evidence has linked per-and polyfluoroalkyl substances (PFAS)
exposure could be linked to the disturbance of gestational glucolipid metabolism, but the …

Emerging epidemiological evidence indicates potential associations between gestational
perfluorobutane sulfonate (PFBS) exposure and adverse metabolic outcomes in offspring …

Abstract Background Perfluoroalkyl substances (PFASs) exist extensively and several of
these have been verified to be toxic. Prenatal exposure to PFASs has attracted much …

Background Biomonitoring studies have shown the presence of structurally diverse
perfluoroalkyl acids (PFAAs) in humans but only a few studies are available regarding the …

Per-and polyfluoroalkyl substances (PFASs) are hypothesized to trigger gestational diabetes
mellitus (GDM) through modulation of glucose metabolism. However, studies investigating …

Perfluoroalkyl acids (PFAAs) are globally present in the environment and are widely
distributed in human populations and wildlife. The chemicals are ubiquitous in human body …

Perfluorohexanesulfonic acid (PFHxS) is a short-chain perfluoroalkyl substance widely used
to replace the banned perfluorooctanesulfonic acid (PFOS) in various industrial and …

Background: Perfluorohexane sulfonate (PFHxS) is a frequently detected per-and
polyfluoroalkyl substance in most populations, including in individuals who are pregnant, a …

Although previous studies have reported an association between maternal serum
perfluoroalkyl substance (PFAS) exposure and gestational diabetes mellitus (GDM) risk …